Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-014336
Filing Date
2024-05-23
Accepted
2024-05-23 17:45:16
Documents
1
Period of Report
2024-05-23

Document Format Files

Seq Description Document Type Size
1 form4-05232024_050506.html 4  
1 form4-05232024_050506.xml 4 9133
  Complete submission text file 0001415889-24-014336.txt   10584
Mailing Address 1800 KRAFT DRIVE, SUITE 216 BLACKSBURG VA 24060
Business Address 1800 KRAFT DRIVE, SUITE 216 BLACKSBURG VA 24060 540-818-2844
Landos Biopharma, Inc. (Issuer) CIK: 0001785345 (see all company filings)

EIN.: 815085535 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O LANDOS BIOPHARMA, INC. 1800 KRAFT DRIVE, SUITE 216 BLACKSBURG VA 24060
Business Address
Garabedian Christopher Nishan (Reporting) CIK: 0001843665 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39971 | Film No.: 24979962